then I think if your endoscopist friend is a convert he needs to be put on the podium by OSL to provide some expert but favourable commentary to the market!
The test now would seem to be the outcomes for the 10 who got resected. We need to see this data, not just survival but also disease free duration . And coming back to your first point would be good to see how many of those resected actually had BR disease at outset.
OSL Price at posting:
12.0¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)